BIO-RAD Laboratories (NYSE: BIO) net income
BIO-RAD Laboratories reported a net profit of $759.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $1,844m. Its net margin was 29.4%. Earnings per share were $27.87.
BIO-RAD Laboratories's best year of the last 10 was fiscal 2021. It reported a loss in 3 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $759.9m | — | 29.4% | $27.87 |
| 2024 | −$1,844m | — | −71.9% | −$65.36 |
| 2023 | −$637.3m | — | −23.9% | −$21.82 |
| 2022 | −$3,628m | −185.3% | −129.5% | −$121.79 |
| 2021 | $4,254m | +11.5% | 145.6% | $142.33 |
| 2020 | $3,814m | +116.9% | 149.8% | $127.86 |
| 2019 | $1,759m | +381.0% | 76.1% | $58.93 |
| 2018 | $365.6m | +199.1% | 16.0% | $12.25 |
| 2017 | $122.2m | +370.2% | 5.7% | $4.12 |
| 2016 | $26.0m | — | 1.3% | $0.88 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
BIO-RAD Laboratories net income compared with its sector
By net income for its latest fiscal year, BIO-RAD Laboratories ranks 51st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of BIO-RAD Laboratories, 29.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 49th | Steris | $782.3m | 13.2% |
| 50th | Royalty Pharma | $770.9m | 32.4% |
| 51st | BIO-RAD Laboratories | $759.9m | 29.4% |
| 52nd | DaVita | $746.8m | 5.5% |
| 53rd | Zimmer Biomet | $705.1m | 8.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of BIO-RAD Laboratories
- How much did BIO-RAD Laboratories earn in fiscal 2025?
- BIO-RAD Laboratories reported a net profit of $759.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $1,844m.
- What are the earnings per share of BIO-RAD Laboratories?
- They were $27.87 in fiscal 2025, compared with −$65.36 in fiscal 2024.
- What is the net margin of BIO-RAD Laboratories?
- In fiscal 2025 its net profit was 29.4% of its revenue.
- What was the most profitable year for BIO-RAD Laboratories?
- Of its last 10 fiscal years, fiscal 2021, with $4,254m.
- Where does BIO-RAD Laboratories rank in its sector by net income?
- It ranks 51st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for BIO-RAD Laboratories come from?
- From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that BIO-RAD Laboratories files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BIO-RAD Laboratories: the BIO-RAD Laboratories page · annual accounts · revenue.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.